Trappin2/elafin (referred to hereafter as elafin) expression has been reported to be raised in fetal membranes from women with preterm prelabour rupture of membranes (PPROM)8 and reduced in cervicovaginal fluid (CVF) from women with bacterial vaginosis (BV)9. This evidence concerns the gene PI3 and bacterial vaginosis.